Lipid-lowering with statins and fibrinolytic parameters.
作者信息
Jovin I S, Heidinger K, Taborski U, Muller-Berghaus G
出版信息
Eur Heart J. 1997 Sep;18(9):1516. doi: 10.1093/oxfordjournals.eurheartj.a015483.
Abstract
摘要
相似文献
1
Lipid-lowering with statins and fibrinolytic parameters.他汀类药物降脂与纤溶参数
Eur Heart J. 1997 Sep;18(9):1516. doi: 10.1093/oxfordjournals.eurheartj.a015483.
2
Efficacy of low-density-lipoprotein lowering with statins.
Lancet. 1994 Sep 3;344(8923):683.
3
Antiatherothrombotic properties of statins: implications for cardiovascular event reduction.他汀类药物的抗动脉粥样硬化血栓形成特性：对减少心血管事件的影响。
JAMA. 1998 May 27;279(20):1643-50. doi: 10.1001/jama.279.20.1643.
4
C-reactive protein and lipids may respond differently to statins.
Curr Atheroscler Rep. 2003 Jan;5(1):9. doi: 10.1007/s11883-003-0061-7.
5
Randomized comparative study of the effects of treatment with once-daily, niacin extended-release/lovastatin and with simvastatin on lipid profile and fibrinolytic parameters in Taiwan.台湾地区每日一次服用烟酸缓释/洛伐他汀与辛伐他汀治疗对血脂谱和纤溶参数影响的随机对照研究。
Kaohsiung J Med Sci. 2006 Jun;22(6):257-65. doi: 10.1016/S1607-551X(09)70309-2.
6
Statins as immunomodulatory drugs.他汀类药物作为免疫调节药物。
Adv Exp Med Biol. 2001;495:283-8. doi: 10.1007/978-1-4615-0685-0_39.
7
Implications of 4S evidence on baseline lipid levels.4S研究证据对基线血脂水平的影响。
Lancet. 1995 Jul 15;346(8968):181.
8
Efficacy of low-density-lipoprotein lowering with statins.
Lancet. 1994 Sep 3;344(8923):683-4.
9
Effects of HMG-CoA reductase inhibitors on coagulation and fibrinolysis processes.HMG-CoA还原酶抑制剂对凝血和纤维蛋白溶解过程的影响。
Drugs. 2003;63(17):1821-54. doi: 10.2165/00003495-200363170-00005.
10
Efficacy of low-density-lipoprotein lowering with statins.
Lancet. 1994 Sep 3;344(8923):684.
Zotero 插件